Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease

Detalhes bibliográficos
Autor(a) principal: Barreto,Iasmin dos Santos
Data de Publicação: 2021
Outros Autores: Santos,Raquel Oliveira dos, Rocha,Raquel, Souza,Claudineia de, Almeida,Naiade, Vieira,Luiza Valois, Leiróz,Rafael, Sarno,Manoel, Daltro,Carla, Cotrim,Helma Pinchemel
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Associação Médica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021001001233
Resumo: SUMMARY OBJECTIVE: To evaluate the association between muscle mass depletion and compromising of the cell membrane integrity and clinical–anthropometric characteristics in patients with nonalcoholic fatty liver disease. METHODS: This observational study evaluated waist circumference, body mass index, and waist-to-height ratio in patients with nonalcoholic fatty liver disease. Skeletal mass index corrected by weight and impairment of cell membrane integrity were assessed using bioelectrical impedance analysis. RESULTS: In 56 patients, muscle mass depletion was observed in 62.5% and cell membrane impairment in 28.6%. The metabolic syndrome and elevated aspartate aminotransferase were the only clinical factors associated with mass depletion (p<0.05). The linear regression analysis showed association between skeletal mass index and waist-to-height ratio and waist circumference, after adjustments (p<0.05). The phase angle value was not different between those with and without mass depletion, and also it did not have correlation with skeletal mass index and clinical parameters (p>0.05). CONCLUSIONS: The prevalence of mass depletion and cell membrane impairment was higher in patients with nonalcoholic fatty liver disease. The muscle mass depletion was associated with central obesity, aspartate aminotransferase elevated, and metabolic syndrome; however, the phase angle is not associated with clinical and anthropometric data.
id AMB-1_3985a6d69c3e9d66612e883e45ee0966
oai_identifier_str oai:scielo:S0104-42302021001001233
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver diseaseNon-alcoholic fatty liver diseaseSkeletal muscleBioelectrical impedanceObesityCentral obesitySUMMARY OBJECTIVE: To evaluate the association between muscle mass depletion and compromising of the cell membrane integrity and clinical–anthropometric characteristics in patients with nonalcoholic fatty liver disease. METHODS: This observational study evaluated waist circumference, body mass index, and waist-to-height ratio in patients with nonalcoholic fatty liver disease. Skeletal mass index corrected by weight and impairment of cell membrane integrity were assessed using bioelectrical impedance analysis. RESULTS: In 56 patients, muscle mass depletion was observed in 62.5% and cell membrane impairment in 28.6%. The metabolic syndrome and elevated aspartate aminotransferase were the only clinical factors associated with mass depletion (p<0.05). The linear regression analysis showed association between skeletal mass index and waist-to-height ratio and waist circumference, after adjustments (p<0.05). The phase angle value was not different between those with and without mass depletion, and also it did not have correlation with skeletal mass index and clinical parameters (p>0.05). CONCLUSIONS: The prevalence of mass depletion and cell membrane impairment was higher in patients with nonalcoholic fatty liver disease. The muscle mass depletion was associated with central obesity, aspartate aminotransferase elevated, and metabolic syndrome; however, the phase angle is not associated with clinical and anthropometric data.Associação Médica Brasileira2021-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021001001233Revista da Associação Médica Brasileira v.67 n.9 2021reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.20201016info:eu-repo/semantics/openAccessBarreto,Iasmin dos SantosSantos,Raquel Oliveira dosRocha,RaquelSouza,Claudineia deAlmeida,NaiadeVieira,Luiza ValoisLeiróz,RafaelSarno,ManoelDaltro,CarlaCotrim,Helma Pinchemeleng2021-11-17T00:00:00Zoai:scielo:S0104-42302021001001233Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2021-11-17T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease
title Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease
spellingShingle Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease
Barreto,Iasmin dos Santos
Non-alcoholic fatty liver disease
Skeletal muscle
Bioelectrical impedance
Obesity
Central obesity
title_short Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease
title_full Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease
title_fullStr Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease
title_full_unstemmed Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease
title_sort Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease
author Barreto,Iasmin dos Santos
author_facet Barreto,Iasmin dos Santos
Santos,Raquel Oliveira dos
Rocha,Raquel
Souza,Claudineia de
Almeida,Naiade
Vieira,Luiza Valois
Leiróz,Rafael
Sarno,Manoel
Daltro,Carla
Cotrim,Helma Pinchemel
author_role author
author2 Santos,Raquel Oliveira dos
Rocha,Raquel
Souza,Claudineia de
Almeida,Naiade
Vieira,Luiza Valois
Leiróz,Rafael
Sarno,Manoel
Daltro,Carla
Cotrim,Helma Pinchemel
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Barreto,Iasmin dos Santos
Santos,Raquel Oliveira dos
Rocha,Raquel
Souza,Claudineia de
Almeida,Naiade
Vieira,Luiza Valois
Leiróz,Rafael
Sarno,Manoel
Daltro,Carla
Cotrim,Helma Pinchemel
dc.subject.por.fl_str_mv Non-alcoholic fatty liver disease
Skeletal muscle
Bioelectrical impedance
Obesity
Central obesity
topic Non-alcoholic fatty liver disease
Skeletal muscle
Bioelectrical impedance
Obesity
Central obesity
description SUMMARY OBJECTIVE: To evaluate the association between muscle mass depletion and compromising of the cell membrane integrity and clinical–anthropometric characteristics in patients with nonalcoholic fatty liver disease. METHODS: This observational study evaluated waist circumference, body mass index, and waist-to-height ratio in patients with nonalcoholic fatty liver disease. Skeletal mass index corrected by weight and impairment of cell membrane integrity were assessed using bioelectrical impedance analysis. RESULTS: In 56 patients, muscle mass depletion was observed in 62.5% and cell membrane impairment in 28.6%. The metabolic syndrome and elevated aspartate aminotransferase were the only clinical factors associated with mass depletion (p<0.05). The linear regression analysis showed association between skeletal mass index and waist-to-height ratio and waist circumference, after adjustments (p<0.05). The phase angle value was not different between those with and without mass depletion, and also it did not have correlation with skeletal mass index and clinical parameters (p>0.05). CONCLUSIONS: The prevalence of mass depletion and cell membrane impairment was higher in patients with nonalcoholic fatty liver disease. The muscle mass depletion was associated with central obesity, aspartate aminotransferase elevated, and metabolic syndrome; however, the phase angle is not associated with clinical and anthropometric data.
publishDate 2021
dc.date.none.fl_str_mv 2021-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021001001233
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021001001233
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1806-9282.20201016
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.67 n.9 2021
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212836540678144